Related Experiment Video
Updated: Nov 29, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Ischemic stroke and purpuric dermatitis as COVID-19-related complications in a peritoneal dialysis patient
Alberto de Lorenzo Alvarez1, Ángela Revilla2, Teresa Corbalán3
1Department of Nephrology, Hospital Universitario de Getafe, Carr. Madrid-Toledo, Km 12,500, Getafe, 28905, Madrid, Spain. albertodelorenzoalvarez@gmail.com.
Insights
Patients undergoing dialysis face higher risks from COVID-19. This case report details a peritoneal dialysis patient experiencing purpuric dermatitis and ischemic stroke following SARS-CoV-2 infection, highlighting the need for further research.
Area of Science:
- Nephrology
- Infectious Diseases
- Dermatology
- Neurology
Background:
- Patients on dialysis, particularly those with comorbidities, are at increased risk for severe coronavirus disease 2019 (COVID-19).
- Cutaneous manifestations and thrombotic events are recognized, though infrequent, complications of SARS-CoV-2 infection.
Abstract:
Patients on dialysis may have an elevated risk of severe coronavirus disease 2019 (COVID-19) and its complications due to their high prevalence of comorbidities. Here we describe the case of an 80-year-old male undergoing peritoneal dialysis with a moderate SARS-CoV-2 infection who developed a purpuric dermatitis and ischemic stroke after successful recovery from his bilateral pneumonia. Erythemato-papular lesions affecting trunk and lower limbs appeared 17 days after the onset of SARS-CoV-2 symptoms. These kind of lesions are an infrequent cutaneous manifestation of COVID-19. The pathology revealed a moderate purpuric dermatitis affecting superficial dermis and corticoesteroids were prescribed achieving complete resolution. Arterial thrombosis affecting cerebellar vermis emerged 30 days after the onset of COVID-19 symptoms. It occurred 5 days after withdrawal of antithrombotic prophylaxis that the patient received from his admission until 2 weeks after discharge. He completely recovered from his paresis and continued on his regular antiaggregation therapy. This is the first case report published of a patient with PD with such COVID-19-related complications. More experience is needed to determine the appropriate length of antithrombotic prophylaxis especially in high-risk individuals.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Hemodialysis II: Procedure and Complications
Peritoneal Dialysis III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Peritoneal Dialysis I: Introduction and Procedure
Nephrotic Syndrome III : Nursing Management

